Managing MDR infections in the ICU: antibiotics, therapy duration and immune modulation

This webinar explores the latest evidence‑based strategies for managing multidrug‑resistant (MDR) infections in critically ill patients. Experts discuss new antibiotics for MDR Gram‑negative pathogens, optimal duration of therapy in the ICU, and how immune modulation is reshaping treatment for hospital‑acquired pneumonia. Part 2 of the three-part webinar series, Critical Care Infectious Diseases – Hot Topics and Upcoming Trends, organized by the ISAC Infections in the ICU & Sepsis Working Group, ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP), and King’s Critical Care, King’s College Hospital London. PROGRAMME 00:00 Start 01:45 New antibiotics for tackling MDR Gram-Negative Infections in the ICU - Matteo Bassetti, Italy 25:25 Old antibiotics in a new era: rescue therapies for MBL-GNBs - Demosthenes Makris, Greece 52:39 Duration of antibiotic therapy for severe infection in critically ill patients: how long is long enough? - Jean-Francois Timsit, France 1:23:25 Immune modulation in critical illness: reframing hospital-acquired pneumonia treatment through the host lens - Antoine Roquilly, France #CriticalCare #InfectiousDiseases #MDRInfections #ICU #AntibioticStewardship